1. Chemotherapy:
   • Mechanism: Chemotherapy can damage ovarian follicles, leading to reduced ovarian reserve and potentially causing premature ovarian failure or early menopause.
   • Factors Influencing Risk: The impact on fertility depends on the type and dose of chemotherapy, the patient’s age, and ovarian reserve prior to treatment.
2. Radiation Therapy:
   • Abdominal and Pelvic Radiation: Direct radiation to the ovaries can significantly impair fertility. Even radiation to other parts of the body, such as the breast or chest, may have some indirect effects.
   • Total Body Irradiation: Often used in preparation for bone marrow transplant, can have profound effects on ovarian function.
3. Hormone Therapy:
   • Tamoxifen: Used to treat hormone receptor-positive breast cancer, tamoxifen is typically prescribed for several years. While it doesn’t directly damage the ovaries, it is not recommended to conceive while on tamoxifen due to potential risks to the fetus.
   • Aromatase Inhibitors: Generally used in postmenopausal women, but when used in a premenopausal context, they can suppress ovarian function.

For women who wish to preserve their fertility before starting breast cancer treatment, there are several options available:

1. Embryo Freezing:
   • Procedure: Oocytes are harvested following ovarian stimulation and fertilized with sperm to create embryos, which are then frozen for future use.
   • Considerations: Requires a partner or sperm donor. The process typically takes about 2-3 weeks, which may delay cancer treatment.
2. Egg Freezing:
   • Procedure: Similar to embryo freezing, but the eggs are frozen unfertilized. This option is suitable for women without a current partner.
   • Success Rates: Generally lower success rates compared to embryo freezing but still a viable option.
3. Ovarian Suppression:
   • GnRH Agonists: Medications such as leuprolide or goserelin can be used during chemotherapy to temporarily shut down ovarian function, potentially preserving fertility.
   • Efficacy: Research on the efficacy of this method is mixed, but it is considered a relatively simple and non-invasive option.
4. Ovarian Tissue Cryopreservation:
   • Procedure: A surgical procedure to remove and freeze ovarian tissue, which can later be reimplanted.
   • Experimental: Still considered experimental but has shown promising results.
5. Ovarian Transposition:
   • Procedure: Surgically moving the ovaries out of the radiation field if treatment involves the pelvis or lower abdomen.
   • Efficacy: Can reduce the risk of radiation-induced ovarian damage.

1. Timing:
   • Resuming Menstrual Cycles: Many oncologists recommend waiting until menstrual cycles have returned and stabilized before attempting pregnancy.
   • Risk of Recurrence: Current guidelines generally suggest waiting about 2-3 years after completing treatment to assess for early recurrence risks, but this may vary based on individual circumstances.
2. Safety:
   • Hormone Receptor-Positive Cancer: Concerns exist about the effects of pregnancy-related hormonal changes on cancer recurrence. However, recent studies indicate that pregnancy does not significantly increase the risk.
3. Monitoring:
   • Regular Follow-Up: Close monitoring during pregnancy by a multidisciplinary team including oncologists, obstetricians, and maternal-fetal medicine specialists is essential.

• Reproductive Endocrinologists: Consulting with fertility specialists who have experience with cancer patients can provide a comprehensive fertility preservation plan.
• Oncologists: Open communication about fertility desires before and during treatment planning is crucial.
• Mental Health Support: Counseling and support groups can help manage the emotional impact of fertility concerns related to breast cancer.

• Insurance Coverage: Insurance coverage for fertility preservation varies and can be a significant concern. It's important to explore insurance plans' fertility benefits and seek financial assistance programs if needed.
• Financial Assistance: Organizations and grants are available to help with the costs of fertility preservation for cancer patients.

Fertility considerations are a crucial aspect of breast cancer treatment for premenopausal women. At the Weiser Family Center for Breast Cancer, we understand early consultation with a multidisciplinary team can help identify the most appropriate fertility preservation options and develop a treatment plan that aligns with the patient's desires and medical needs.  
 

Further reading:

• Breast Cancer & Sexual Health
• Breast Cancer & Young Women
• Pregnancy & Breast Cancer
  
   

Related services offered by the U-M Health Rogel Cancer Center:

• Weiser Family Center for Breast Cancer
• Fertility Preservation Program for Cancer Patients
• Weiser Family Center for Breast Cancer Peer Mentoring Program